Background: Amongst the largest Pharma companies in domestic market with Net Sales of INR 171.2bn with a strong brand portfolio. R&D; cost is in excess of 13% of Sales. Exports account for 73% with Developed Markets (DM) at 58% and EM at 15%. Sales Mix: API - 10%, Domestic Formulations - 25%, DM Formulations - 56%, EM Formulations - 9%. Historically strong in anti-TB segment, has built expertise in fermentation based products and segments like...